Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ES-285

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
SummaryBackground ES-285 (spisulosine) is a novel compound derived from the marine mollusk Spisula polynoma with evidence of… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
SummaryBackground ES-285 (Spisulosine) is a novel marine compound with antitumor activity in preclinical studies. A phase I study… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2009
2009
A dose-escalation, phase I study evaluated the safety, pharmacokinetics, pharmacogenomics, and efficacy of ES-285, a novel agent… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
During the past decades, intense attention has been focused on the anti-tumor properties of marine compounds which some of them… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2008
Review
2008
The chemical, biological and ecological diversity of the marine ecosystem has contributed immensely in the discovery of extremely… Expand
Is this relevant?
2006
2006
ES-285 x HCl is a novel marine-derived anticancer agent isolated from the clam Spisula polynyma. The compound is pharmaceutically… Expand
Is this relevant?
2005
2005
4111 Introduction: ES-285 is a novel anti-cancer agent originally isolated from the North Atlantic Clam, Spisula polynyma… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Nature has been instrumental as a source for therapeutics. Despite the fact that we live in an oceanic planet, a number of… Expand
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • table 2
Is this relevant?
2003
2003
Chromophor and fluorophor addition reactions involving phenylisothiocyanate (PITC) and dansyl chloride (DC) were optimized to… Expand
Is this relevant?
2003
2003
A method was developed for the quantitative analysis of the novel anticancer agent ES-285 (spisulosine; free base) in human… Expand
Is this relevant?